AAPP 2023 takes networking to new levels with daily opportunities to participate in a range of unique interactions with other attendees. Attendees may choose based on their availability, preferred type of networking, and practice-based interests. Networking events do not offer ACPE credit and are only available to in-person attendees in Atlanta, Georgia unless otherwise noted.
Take advantage of these opportunities to expand your network of colleagues and improve your practice.
*Will be live-streamed for virtual attendees.
Sunday, April 16: 10:00-11:00 AM
In July of 2023, a new ASHP Pharmacy Residency standard will take effect for all pharmacy residency programs seeking accreditation. Parts of the new standard may necessitate changes to the way residency programs operate as well as how a program demonstrates compliance with the standard in an accreditation survey. In this Idea Exchange, key highlights of changes in the new standard will be discussed, including:
Moderator: Jeanne Peterson, PharmD, BCPP, Clinical Pharmacy Specialist Supervisor, VA Portland Health Care System, Portland, OR
Speaker: Brendon Hogan, PharmD, BCPP, Clinical Pharmacy Manager, Central Texas VHCS, Temple, TX
Comprehensive medication management (CMM) is a patient centered approach to optimize medication use and improve patient health outcomes. CMM is delivered by a clinical pharmacist working in collaboration with the patient and other healthcare providers. Through the CMM process, each medication that a patient is taking is assessed for indication, effectiveness, safety, and adherence. CMM includes an individualized care plan that achieves the intended goals of therapy with appropriate follow-up to determine actual patient outcomes. CMM has demonstrated improvement in patient clinical outcomes, resulted in fewer hospital and emergency department visits, has had a positive impact on cost avoidance and return-on-investment, and has improved the clinician and patient experience with care. This session will provide attendees with information regarding the intent of CMM, the framework for delivering CMM, methods for incorporating CMM into the interdisciplinary practice model, and elements of practice management needed to support CMM with a focus on psychiatric care.
This session will offer a forum for those with any level of CMM experience (none to expert!) to share ideas and success stories, ask questions, and brainstorm solutions to challenges encountered when practicing CMM. Finally, this session will provide attendees with a venue to collaborate with their colleagues to plan for creating a new CMM service or refining a service that they have already established.
Groups are an important component of a psychiatric care plan. They are a cost-effective treatment that aids in symptom resolution and social interaction. Therapy is a first-line treatment for many mental illnesses, and many psychiatric units do not have the resources for individual therapy. Groups can provide some of these same benefits.
Students and residents often do not have experience leading group sessions. If learners are supported properly, groups can instill confidence, enhance listening skills, and heighten presentation skills. Learners often state that leading a group session is one of the most meaningful components of their rotation. The purpose of this idea exchange is to discuss teaching principals to set your learners up for success as they lead their first groups. We will also share and discuss what goes well and what learners struggle with as they provide groups for patients.
Monday, April 17: 1:00-2:00 PM
Amyotrophic Lateral Sclerosis (ALS) is a debilitating and degenerative disease with no cure. For many years, treatment options were limited. Since 2017, there has been increasing interest in the treatment of ALS, with the approval of edaravone in 2017, and more recently sodium phenylbutyrate and taurursodiol in 2022. Prior to edaravone, the only FDA approved treatment option for treatment of ALS was riluzole. In this idea exchange, we will review data and clinical significance of existing pharmacotherapies for ALS. We will also discuss supportive therapies for management of mood, spasticity, and sialorrhea. In addition to discussing current treatment approaches, we plan to discuss opportunities for psychiatric pharmacists to utilize their unique skillset to assist in the management of ALS in an interdisciplinary setting.
Monday, April 17: 2:10-3:10 PM
A lack of leadership experience and skills related to addressing DEI related issues has been cited as a primary cause for the lag in progress towards improvement (Scott 2022). For students and healthcare professionals, being able to provide quality patient care involves understanding the cultural differences and beliefs of our patients and of each other. Learning, promoting, and incorporating DEI practices extends into all areas of pharmacy. A focus on inclusive practices can positively impact student and practitioner learning, including how lack of inclusivity or the presence of unconscious bias could negatively impact experiences. In a joint effort with the Teaching Community, the topic of DEI throughout pharmacy education and practice will be discussed.
Monday: April 17: 3:30-4:30 PM
The treatment of neuropsychiatric symptoms of dementia can be challenging. Most medications used for behavioral symptoms in dementia are typically first assessed in primary psychiatric disorders such as depression, bipolar disorder, schizophrenia or sleep disorders. It is difficult to target behaviors with medications unique to dementia as the symptom-specific biology for behavioral issues remains unclear in some instances. However, progress is being made in clinical trials, with some medications showing promise in the treatment of neuropsychiatric symptoms of dementia. In this idea exchange we will discuss new medications used to target neuropsychiatric symptoms and their evaluation process, available evidence for the treatment of various behavioral symptoms, and challenges associated with the methods used in evaluating medications for neuropsychiatric symptoms of dementia.
Tuesday: April 18: 7:15-8:15 AM
Despite evidence to support gold standard care for patients with substance use disorders (SUD), we face many legal barriers to providing this care uniformly. This year, one of the most groundbreaking changes occurred to remove the X-waiver and hopefully expand access to buprenorphine. However, uptake of this change make take time and the legal status of pharmacist controlled substance prescribing and harm reduction materials still varies across the country. As key players in providing SUD care, psychiatric pharmacists must be prepared to advocate for change within our systems and local policies. We invite community members to share their challenges and successes with navigating these legal and systemic barriers in hopes of providing you with ample resources to effect change in your own practice.
Tuesday, April 18: 3:30-4:30 PM
Mental health conditions are common in children and adolescents, with one in five diagnosed with a mental health condition or a developmental disorder. Despite high rates, few will receive prompt, specialized psychiatric treatment. The COVID-19 pandemic and racial injustice have contributed to soaring rates of mental health challenges among children, adolescents, and their families. Pediatric organizations came together to declare a National State of Emergency in children’s mental health in 2021 to advocate for improved access to care. Psychiatric pharmacists play a critical role in answering this call to action. The Child and Adolescent Psychiatry community will host a panel of psychiatric pharmacists with extensive experience in CAP. The panel will share unique elements of current practice, clinical pearls working with children and their families, innovative treatment approaches, among other topics.
Moderator: Danielle Stutzman PharmD, BCPP, Psychiatric Pharmacist, Pediatric Mental Health Institute, Children’s Hospital Colorado, Aurora, CO
The challenges and benefits of participating in collaborative research projects will be discussed. An upcoming opportunity for collaborative research through AAPP will be briefly touched on. Ideas on how to successfully identify potential collaborators and establish working relationships will be discussed.
Moderator: Geoff Brown, PharmD, Buffalo Psychiatric Center, Co-investigator, GPI Clinical Research, Buffalo, NY
Speaker: Julie Cunningham, PharmD, BCPP, Associate Chief Pharmacy Office Practice and Research, Mayo Clinic, Rochester, MN
Sunday, April 16, 4:45-5:05 PM
The Judith J. Saklad Memorial Award celebrates the life and work of the late Judith J. Saklad. Dr. Saklad was Clinical Pharmacologist and Clinical Coordinator of Pharmaceutical Services at San Antonio State School and Clinical Assistant Professor of Pharmacy and Pharmacology at The University of Texas at Austin and the University of Texas Health Science Center at San Antonio. This award is presented annually to a senior psychiatric pharmacy practitioner who has achieved a level of professional distinction and demonstrates a continuing dedication to the practice of psychiatric pharmacy. AAPP is pleased to announce the recipient of the 2023 Judith J. Saklad Memorial Award, Charles Caley, PharmD, BCPP. Dr. Caley will accept the award on Sunday, April 16, following an afternoon of programming.
Sunday, April 16, 5:05-6:00 PM
Participate in discussions with the AAPP Board of Directors on issues critical to the profession and AAPP as an organization. The Board will update attendees on the highest priority issues and activities within the association while also providing the opportunity for participant questions and input. Following the Forum, the poster award winners will be announced!
Sunday, April 16, 6:15-7:15 PM
Join us for an evening of celebration to honor outgoing AAPP President Cindy Gutierrez!
Although there is no scheduled session for viewing online posters, in-person and virtual attendees may view all posted poster PDFs at their convenience. Authors will publish posters online closer to the event!
Monday, April 17, 5:45-7:15 PM, Grand Hall West: Students, Pharmacists, and other Health Care Professionals
Tuesday, April 18, 4:30-6:00 PM, Grand Hall West: Residents and Fellows
Two poster sessions round out the AAPP 2023 schedule on Monday and Tuesday evenings. During scheduled sessions, poster authors will be available at their posters to discuss the research and answer your questions.